• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Anti Infectives: World Market, 2nd Edition, Vol II: Antibacterials

$2,995.00 – $5,990.00

Clear
SKU: KLI1399449 Categories: Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 276
  • Description
  • Table of Contents
  • Latest reports

Description

The market for antibiotics has changed and a knowledge of the current drug resistance situation is critical before operating in this marketplace. The effectiveness of many antibacterials (antibiotics) is being reduced as more and more types of bacteria become resistant to them.

These and other developments are covered in Kalorama’s Anti-Infectives, World Markets, Vol. II: Antibacterials providing extensive detail on the anti-bacterial market, including the following critical trends:

  • Drug resistance and Interactions
  • Antibiotic Abuse
  • Antibiotic Cycling
  • Addressing Market Trends
  • Antibiotic Use in Agriculture
  • Antibiotic Education
  • Children and Bacterial Resistance
  • The Elderly and Bacterial Resistance
  • Compromised Individuals and Bacterial Resistance
  • Screening Hospital Patients
  • Side Effects of Antibiotics
  • Partnerships and Alliances
  • Environment and Drug Resistance
  • Methicillin Resistant Staphylococcus Aureus

The title is part of Kalorama Information’s Anti-Infectives series, which represents a total decison and problem-solving support tool for decision makers in the pharmaceutical industry dealing with anti-infectives, or those assisting customers or looking at investments in this area.

Because of antibiotic resitance and other changing dynamics, knowledge of issues and trends is necessary to operate the antibacterials market.

In this, the second volume of Kalorama Information’s Anti-Infective Markets series, the antibacterial drug market is broken down into seven general categories based on drug class:

  • cephalosporins
  • macrolides
  • penicillins
  • quinolones
  • sulfonamides
  • tetracyclines
  • other misc. antibiotics

There is a significant trend shift occuring in the antibacterials market since Kalorama Information’s last edition in 2005. Anti-Infectives Vol. II: Antibacterials covers that shift in detail. For each marketplace segment, Market Size, Growth and Share are provided, and revenue is forecasted to 2011 are provided. Current products are discussed and new pipeline products are assessed. This report also breaks out marketplace data by Infection Type the only publication to do so. In total, over 100 Tables and Figures provide accessible data on this growing market, a depth of coverage unsurpassed by any competitive study.

The following companies are profiled as part of this report:

  • Abbott Laboratories
  • AstraZeneca
  • Bayer Schering Pharma
  • Cubist Pharmaceuticals
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Johnson & Johnson Group
  • King Pharmaceuticals
  • Merck & Company, Inc.
  • Pfizer, Inc.
  • Roche
  • Sanofi-Aventis
  • Wyeth

Table of Contents

Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

Introduction  The World Market for Anti-Infectives Volume 2:            

  • Antibacterial Drugs
  • Introduction to pathogens
    • Classification of Antibacterial Organisms
    • Antimicrobial Spectrum
    • Bacterial Resistance
    • Principles of Anti-infective Therapy
    • Infecting Organism
    • Antibiotic Sensitivity Testing
    • Site of Infection
    • Host Defenses and Organ Function
    • Antibiotic Pharmacokinetics
    • Monitoring Therapy
    • Combination Therapy and Prophylactic Use
  • Demographics and Statistics

Issues and Trends Affecting the Antibacterial Drug Market      

  • introduction
  • Drug Resistance and Interactions
  • Antibiotic Abuse
  • Antibiotic Cycling
  • addressing market trends
  • Antibiotic use in Agriculture
  • Antibiotic Education
  • Children and Bacterial resistance
  • The Elderly and Bacterial Resistance
  • Compromised Individuals and Bacterial Resistance
  • Screening Hospitalized patients
  • Side Effects of Antibiotics
  • Partnerships and Alliances
  • Environment and Drug  Resistance
  • Methicillin-resistant Staphylococcus Aureus (MRSA)

Cephalosporin Antibiotics

  • Overview
  • Description of Products
    • First Generation Cephalosporins
    • Cephalexin (Keflex, Advancis Pharmaceuticals)
    • Cefazolin (Ancef, GlaxoSmithKline; Cefamezin, Astellas)
    • Cefadroxil (Duricef, Bristol-Myers Squibb/Warner Chilcot)
    • Second Generation Cephalosporins
    • Cefuroxime (Ceftin, GlaxoSmithKline)
    • Cefoxitin (Mefoxin, Merck)
    • Third Generation Cephalosporins
    • Cefotaximen (Claforan offered by Sanofi-Aventis)
    • Cefoperazone (Cefobid, Pfizer)
    • Ceftibutin (Cedax, Shionogi)
    • Ceftizoxime (Cefizox, Astellas)
    • Ceftriaxone (Rocephin, Roche)
    • Ceftazidime (Fortaz, GlaxoSmithKline)
    • Cefixime (Suprax, Wyeth/Lupin Pharmaceuticals)
    • Cefpodoxime (Vantin, Pfizer)
    • Fourth Generation Cephalosporins
    • Cefepime (Maxipime, Bristol-Myers Squibb)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Macrolide Antibiotics

  • Overview
  • Description of Products
    • Azithromycin (Zithromax, Pfizer; Zmax, Pfizer)
    • Clarithromycin (Biaxin, Abbott Laboratories)
    • Erythromycin (Erythrocin, Abbott Laboratories; EryPed, Abbott Laboratories)
    • Telithromycin (Ketek, Sanofi-Aventis)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Penicillin Antibiotics

  • Overview
  • Natural Penicillins
  • Penicillinase-Resistant Penicillins
  • Broad -Spectrum Penicillins
  • Extended-Spectrum Penicillins

Description of Products

  • Natural Penicillins
  • Penicillin G (Bicillin, King Pharmaceuticals; Pfizerpen, Pfizer)
  • Penicillinase-resistant Penicillins
  • Cloxacillin (Cloxapen, GlaxoSmithKline)
  • Oxacillin (Bactocill, GlaxoSmithKline)
  • Broad-spectrum Penicillins
  • Amoxicillin (Augmentin, GlaxoSmithKline; Amoxil,GlaxoSmithKline)
  • Ampicillin (Unasyn, Pfizer)
  • Extended-spectrum Penicillins
  • Carbenicillin (Geocillin, Pfizer)
  • Piperacillin (Pipracil, Wyeth; Zosyn, Wyeth)
  • Ticarcillin (Timentin, GlaxoSmithKline)

 

Generic Drug Impact and Availability

Research and Development

Market Size and Growth

Competitive Analysis

Quinolone Antibiotics

  • Overview
  • Description of Products
    • Ciprofloxacin (Cipro, Bayer; Proquin XR, Depomed)
    • Gemifloxacin (Factive, LG Chem Ltd. and Oscient Pharmaceuticals)
    • Lomefloxacin (Maxaquin, Unimed)
    • Nalidixic (NegGram, Sanofi-Aventis)
    • Norfloxacin (Noroxin, Merck)
    • Ofloxacin (Floxin, Ortho-McNeil)
    • Moxifloxicin (Avelox, Bayer; Vigamox, Alcon)
    • Levofloxacin (Levaquin, Ortho-McNeil; Tavanic, Sanofi-Aventis; Cravit, Daiichi Sankyo; Quixin, Santen)
    • Gatifloxacin (Zymar, Allergan/Kyorin)
    • Trovafloxacin (Trovan, Pfizer)
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Sulfonamide Antibiotics

  • Overview
  • Description of Products
  • Sulfisoxazole (Gantrisin Pediatric, Roche)
    • Oxytetracycline/Sulfamethizole/Phenazopyridine (Urobiotic, Pfizer)
    • Erythromycin ethylsuccinate and Sulfisoxazole acetyl (Pediazole, Ross)
    • Dapsone (Aczone Gel, QLT USA-Tolmar Inc.)
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Tetracycline Antibiotics

  • Overview
  • Description of Products
  • Generic Drug Impact and Availability
  • Research and Development
  • Market Size and Growth
  • Competitive Analysis

Other Miscellaneous Antibiotics

  • Overview
  • Description of Products
  • Aminoglycosides
    • Amikacin Sulfate (Amikin, Bristol-Myers Squibb)
    • Kanamycin Sulfate (Kantrex, Bristol-Myers Squibb)
    • Neomycin Sulfate (Neo-fradin, X Gen Pharms)
    • Streptomycin Sulfate (Streptomycin, Pfizer)
    • Lincomycin
    • Clindamycin (Cleocin, Pfizer; Clindesse, KV Pharmaceutical Company; Evoclin, Connetics Corp.; Ziana Gel, Medicis/Dow)
    • Chloramphenicol
    • Chloramphenicol  (Chloromycetin,Pfizer)
    • Glycopeptide
    • Vancomycin (Vancocin,  Viropharma)
    • Monobactams
    • Aztreonam (Azactam, Bristol-Myers Squibb)
    • Carbapenems
    • Imipenem/cilastatin (Primaxin, Merck)
    • Meropenem (Merrem, AstraZeneca)
    • Metronidazole
    • Metronidazole (Flagyl, Pfizer; Pylera, Axcan; Metrogel-Vaginal, 3M Pharmaceuticals; MetroGel, Galderma)
    • Antituberculars
    • Rifampicin (Rifater, Sanofi-Aventis)
    • Capreomycin (Capastat sulfate, Eli Lilly & Co.)
    • Ethionamide (Trecator SC, Wyeth)
    • Aminosalicylic acid granules (Paser Granules, Jacobus Pharmaceutical)
    • Cycloserine (Seromycin, Eli Lilly & Co.)
    • Antileprotics
    • Dapsone (Dapsone, Jacobus)
    • Oxazolidinones
    • Linezolid  (Zyvox, Pfizer)
    • Ketolides
    • Telithromycin (Ketek, Sanofi-Aventis)
    • Lipopeptides
    • Daptomycin (Cubicin, Cubist Pharmaceutical)
    • Glycyclines
    • Tigecycline (Tygacil, Wyeth)
    • Generic Drug Impact and Availability
    • Research and Development
    • Market Size and Growth
    • Competitive Analysis

Corporate Profiles

  • Introduction
  • Abbott Laboratories
  • AstraZeneca plc
  • Bayer Schering Pharma AG
  • Cubist Pharmaceuticals, Inc
  • Daiichi Sankyo Co., Ltd.
  • GlaxoSmithKline
  • Johnson & Johnson Group
  • King Pharmaceuticals, Inc.
  • Merck & Company, Inc.
  • Pfizer, Inc.
  • Roche
  • Sanofi-Aventis
  • Wyeth

Company Names and Addresses

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    $1,875.00 – $3,750.00
  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00
  • Placeholder image

    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    $2,246.00 – $4,492.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Refractive Vision Correction – A Market AnalysisDrug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery
Scroll to top